Zura Bio Ltd (ZURA) stock
ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.97−0.07 (-6.75%)
Close on Nov 18, 2026Market cap $92.96MP/E –Yield –
Zura Bio ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Zura Bio's ebitda for the twelve months ending Sep 30, 2026 was -$101.95M. For fiscal 2025 it was -$75.20M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$75.20M | – |
| FY2024 | Dec 31, 2024 | -$55.18M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$28.77M | – |
| Q2 FY2026 | Jun 30, 2026 | -$29.34M | – |
| Q1 FY2026 | Mar 31, 2026 | -$25.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.36M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.52M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.25M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$19.32M | – |
See a number that looks wrong?